Venlafaxine API product is an antidepressant of the SNRI class (reuptake inhibitor of serotonin,
norepinephrine). It works mainly by altering the levels of certain chemicals in the brain that may
become unbalanced causing depression. Marketed under the brand name Effexor is administered
as a sustained release capsule contains venlafaxine hydrochloride. It is being prescribed for
depression also used to treat anxiety and panic disorders. API production is done in any
countries, lets learn a bit more about them.
API production is done in large scale by pharmaceutical companies across the world. In this
content you can read about the top manufacturers of API products across the globe. It was almost
a decade ago these drugs started being sold as generic in the pharmaceutical industry before
which only one company had the brand value related to it.
API production companies
Today, many pharmaceutical companies are venlafaxine API products as a generic drug. It is
available generically in the US since August 2006 and in Canada since December 2006 due to
patent expiry. Studies have shown that the results of the sustained-release version of a lower
number of patients suffering from nausea and hence less drug discontinuation. Venlafaxine XR
Wyeth sells under the brand name Efexor-XR in Australia, New Zealand and Switzerland.
Other extended-release venlafaxine manufacturers are: TAPI, Cobalt Pharmaceuticals Inc.,
Genpharm, Medley, Ratiopharm, penetrating agent Pharmaceuticals, Inc. Laboratoire Riva,
Pharmascience Inc., MedPro, Novopharm Limited, Sandoz, Cipla and Pharma dynamics Intelli
PharmaCeutics. For those of you who want to know more about the same drug venlafaxine
reading the page on the Mayo Clinic website recommended.
These are few of the major API production companies in the world. Today, all these companies
are responsible for API production and selling the drug as generic everywhere. There are
different type of API products available in the market today.